We are live on ! Find out more
CIP

Convergence Investment Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
+8.21%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.25%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$706M
AUM Growth
+$22.2M
Cap. Flow
-$18.7M
Cap. Flow %
-2.65%
Top 10 Hldgs %
13.02%
Holding
439
New
101
Increased
102
Reduced
110
Closed
126

Top Sells

Rank Stock Value
1
EVR icon
Evercore
EVR
+$4.64M
2
DF
Dean Foods Company
DF
+$4.6M
3
AVA icon
Avista
AVA
+$4.2M
4
SAIC icon
Saic
SAIC
+$4.18M
5
PFE icon
Pfizer
PFE
+$4.06M

Sector Composition

Rank Sector Weight
1 Financials 16.13%
2 Industrials 13.97%
3 Healthcare 13.19%
4 Technology 12.92%
5 Consumer Discretionary 10.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACM icon
201
Aecom
ACM
$9.6B
$1.36M 0.19%
36,938
+27,857
+307% +$916K
BC icon
202
Brunswick
BC
$5.33B
$1.35M 0.19%
24,152
+3,472
+17% +$195K
CLF icon
203
Cleveland-Cliffs
CLF
$6.73B
$1.35M 0.19%
+188,852
New +$1.41M
LOPE icon
204
Grand Canyon Education
LOPE
$3.9B
$1.35M 0.19%
+14,860
New +$1.19M
PCH
205
DELISTED
PotlatchDeltic
PCH
$1.34M 0.19%
+26,341
New +$1.25M
RPXC
206
DELISTED
RPX Corporation
RPXC
$1.34M 0.19%
100,719
+51,833
+106% +$680K
BIVV
207
DELISTED
Bioverativ Inc. Common Stock
BIVV
$1.33M 0.19%
23,330
+7,839
+51% +$459K
IVZ icon
208
Invesco
IVZ
$14B
$1.32M 0.19%
37,804
-15,112
-29% -$516K
ACOR
209
DELISTED
Acorda Therapeutics
ACOR
$1.29M 0.18%
+456
New +$1.2M
MAN icon
210
ManpowerGroup
MAN
$2.51B
$1.27M 0.18%
10,793
-2,067
-16% -$231K
NVR icon
211
NVR
NVR
$16.6B
$1.25M 0.18%
+438
New +$1.17M
BLMN icon
212
Bloomin' Brands
BLMN
$766M
$1.25M 0.18%
+70,859
New +$1.29M
VRE
213
DELISTED
Veris Residential
VRE
$1.24M 0.18%
+52,272
New +$1.29M
BCC icon
214
Boise Cascade
BCC
$3B
$1.24M 0.18%
35,402
-1,494
-4% -$45.4K
WMB icon
215
Williams Companies
WMB
$87.3B
$1.24M 0.18%
+41,159
New +$1.25M
F icon
216
Ford
F
$56.3B
$1.22M 0.17%
101,658
+604
+0.6% +$6.81K
PG icon
217
Procter & Gamble
PG
$340B
$1.21M 0.17%
13,304
-12,948
-49% -$1.18M
KMB icon
218
Kimberly-Clark
KMB
$35.9B
$1.19M 0.17%
10,104
+6
+0.1% +$733
JBL icon
219
Jabil
JBL
$35.4B
$1.18M 0.17%
41,399
-50,368
-55% -$1.52M
DECK icon
220
Deckers Outdoor
DECK
$13.7B
$1.18M 0.17%
103,530
+53,610
+107% +$578K
ROL icon
221
Rollins
ROL
$18.1B
$1.16M 0.16%
+56,543
New +$1.09M
DO
222
DELISTED
Diamond Offshore Drilling
DO
$1.16M 0.16%
+79,931
New +$962K
GHDX
223
DELISTED
Genomic Health, Inc.
GHDX
$1.14M 0.16%
35,598
+928
+3% +$29.3K
BANR icon
224
Banner Corp
BANR
$2.45B
$1.13M 0.16%
+18,470
New +$1.05M
FOXF icon
225
Fox Factory Holding Corp
FOXF
$819M
$1.13M 0.16%
+26,136
New +$1.02M

Similar funds

Convergence Investment Partners's Q3 2017 Portfolio in Review

As of Q3 2017, Convergence Investment Partners held 439 positions worth $706M, up 3.2% from $684M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Convergence Investment Partners's Q3 2017 filing shows 101 new, 102 increased, 110 reduced and 126 closed positions. Its largest new stake was Celgene Corp: 35,534 shares worth $5.18M. The largest sale was Evercore, an estimated $4.64M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Industrials and Healthcare.

  • Convergence Investment Partners's largest Q3 2017 buy was Celgene Corp: 35,534 shares worth $5.18M.
  • Convergence Investment Partners added most to Pattern Energy Group Inc. Class A in Q3 2017, an estimated $4.8M increase.
  • Convergence Investment Partners's biggest Q3 2017 reduction was Saic, cutting an estimated $4.18M.
  • Convergence Investment Partners fully exited Evercore in Q3 2017, selling an estimated $4.64M.
  • Convergence Investment Partners's ten largest holdings make up 13% of its $706M portfolio in Q3 2017.
  • Convergence Investment Partners opened 101 new positions and closed 126 in Q3 2017.
  • Convergence Investment Partners's portfolio value rose 3.2% quarter-over-quarter to $706M.

Based on Convergence Investment Partners's 13F filing for Q3 2017, filed 13 Nov 2017.